NasdaqGM - Nasdaq Real Time Price USD
Silexion Therapeutics Corp (SLXN)
At close: November 6 at 4:00 PM EST
After hours: 7:27 PM EST
Breakdown
12/31/2023
12/31/2022
Total Assets
5,256.0000
9,333.0000
Total Liabilities Net Minority Interest
17,312.0000
16,412.0000
Total Equity Gross Minority Interest
-12,056.0000
-7,079.0000
Total Capitalization
-15,476.0000
-10,665.0000
Common Stock Equity
-15,476.0000
-10,665.0000
Capital Lease Obligations
171.0000
271.0000
Net Tangible Assets
-15,476.0000
-10,665.0000
Working Capital
2,783.0000
7,229.0000
Invested Capital
-15,476.0000
-10,665.0000
Tangible Book Value
-15,476.0000
-10,665.0000
Total Debt
171.0000
271.0000
Share Issued
8,151.6500
8,151.6500
Ordinary Shares Number
8,151.6500
8,151.6500
12/31/2022 - 4/7/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
WINT Windtree Therapeutics, Inc.
0.6133
-11.58%
CDT Conduit Pharmaceuticals Inc.
0.1073
+2.00%
CERO CERo Therapeutics Holdings, Inc.
0.0720
-1.77%
SILO Silo Pharma, Inc.
1.1800
+6.31%
SPRC SciSparc Ltd.
0.2395
+4.27%
ADTX Aditxt, Inc.
0.4750
+0.30%
AZTR Azitra, Inc.
0.4941
+2.77%
PBM Psyence Biomedical Ltd.
0.0612
-6.99%
DRMA Dermata Therapeutics, Inc.
1.3500
+7.14%
XRTX XORTX Therapeutics Inc.
1.4500
+1.40%